Skip to main content
Top
Published in: Journal of General Internal Medicine 7/2015

01-07-2015 | Original Article

Building Equity Improvement into Quality Improvement: Reducing Socioeconomic Disparities in Colorectal Cancer Screening as Part of Population Health Management

Authors: Seth A. Berkowitz, MD MPH, Sanja Percac-Lima, MD PhD, Jeffrey M. Ashburner, , MPH, Yuchiao Chang, PhD, Adrian H. Zai, MD PhD MPH, Wei He, MS, Richard W. Grant, MD MPH, Steven J. Atlas, MD MPH

Published in: Journal of General Internal Medicine | Issue 7/2015

Login to get access

ABSTRACT

BACKGROUND

Improving colorectal cancer (CRC) screening rates for patients from socioeconomically disadvantaged backgrounds is a recognized public health priority.

OBJECTIVE

Our aim was to determine if implementation of a system-wide screening intervention could reduce disparities in the setting of improved overall screening rates.

DESIGN

This was an interrupted time series (ITS) analysis before and after a population management intervention.

PARTICIPANTS

Patients eligible for CRC screening (age 52–75 years without prior total colectomy) in an 18-practice research network from 15 June 2009 to 15 June 2012 participated in the study.

INTERVENTION

The Technology for Optimizing Population Care (TopCare) intervention electronically identified patients overdue for screening and facilitated contact by letter or telephone scheduler, with or without physician involvement. Patients identified by algorithm as high risk for non-completion entered into intensive patient navigation.

MAIN MEASURES

Patients were dichotomized as ≤ high school diploma (≤ HS), an indicator of socioeconomic disadvantage, vs. >HS diploma (> HS). The monthly disparity between ≤ HS and > HS with regard to CRC screening completion was examined.

KEY RESULTS

At baseline, 72 % of 47,447 eligible patients had completed screening, compared with 75 % of 51,442 eligible patients at the end of follow-up (p < 0.001). CRC screening completion was lower in ≤ HS vs. >HS patients in June 2009 (65.7 % vs. 74.5 %, p < 0.001) and remained lower in June 2012 (69.4 % vs. 76.7 %, p < 0.001). In the ITS analysis, which accounts for secular trends, TopCare was associated with a significant decrease in the CRC screening disparity (0.7 %, p < 0.001). The effect of TopCare represents approximately 99 additional ≤ HS patients screened above prevailing trends, or 26 life-years gained had these patients remained unscreened.

CONCLUSIONS

A multifaceted population management intervention sensitive to the needs of vulnerable patients modestly narrowed disparities in CRC screening, while also increasing overall screening rates. Embedding interventions for vulnerable patients within larger population management systems represents an effective approach to increasing overall quality of care while also decreasing disparities.
Literature
2.
go back to reference U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2010 Incidence and Mortality Web-based Report. . U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Atlanta. 2013. www.cdc.gov/uscs. Accessed 28 January 2015. U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2010 Incidence and Mortality Web-based Report. . U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Atlanta. 2013. www.​cdc.​gov/​uscs. Accessed 28 January 2015.
5.
go back to reference Steele CB, Rim SH, Joseph DA, King JB, Seeff LC. Colorectal cancer incidence and screening - United States, 2008 and 2010. MMWR Surveill Summ. 2013;62(3):53–60.PubMed Steele CB, Rim SH, Joseph DA, King JB, Seeff LC. Colorectal cancer incidence and screening - United States, 2008 and 2010. MMWR Surveill Summ. 2013;62(3):53–60.PubMed
7.
go back to reference Centers for Disease Control and Prevention. Vital signs: colorectal cancer screening test use—United States, 2012. MMWR Morb Mortal Wkly Rep. 2013;62(44):881–8. Centers for Disease Control and Prevention. Vital signs: colorectal cancer screening test use—United States, 2012. MMWR Morb Mortal Wkly Rep. 2013;62(44):881–8.
8.
10.
go back to reference Baker DW, Brown T, Buchanan DR, Weil J, Balsley K, Ranalli L, et al. Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial. JAMA Intern Med. 2014. doi:10.1001/jamainternmed.2014.2352.PubMed Baker DW, Brown T, Buchanan DR, Weil J, Balsley K, Ranalli L, et al. Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial. JAMA Intern Med. 2014. doi:10.​1001/​jamainternmed.​2014.​2352.PubMed
11.
go back to reference Dietrich AJ, Tobin JN, Cassells A, Robinson CM, Greene MA, Sox CH, et al. Telephone care management to improve cancer screening among low-income women: a randomized, controlled trial. Ann Intern Med. 2006;144(8):563–71.PubMedCentralPubMedCrossRef Dietrich AJ, Tobin JN, Cassells A, Robinson CM, Greene MA, Sox CH, et al. Telephone care management to improve cancer screening among low-income women: a randomized, controlled trial. Ann Intern Med. 2006;144(8):563–71.PubMedCentralPubMedCrossRef
12.
go back to reference Dietrich AJ, Tobin JN, Robinson CM, Cassells A, Greene MA, Dunn VH, et al. Telephone outreach to increase colon cancer screening in medicaid managed care organizations: a randomized controlled trial. Ann Fam Med. 2013;11(4):335–43. doi:10.1370/afm.1469.PubMedCentralPubMedCrossRef Dietrich AJ, Tobin JN, Robinson CM, Cassells A, Greene MA, Dunn VH, et al. Telephone outreach to increase colon cancer screening in medicaid managed care organizations: a randomized controlled trial. Ann Fam Med. 2013;11(4):335–43. doi:10.​1370/​afm.​1469.PubMedCentralPubMedCrossRef
16.
go back to reference Percac-Lima S, Lopez L, Ashburner JM, Green AR, Atlas SJ. The longitudinal impact of patient navigation on equity in colorectal cancer screening in a large primary care network. Cancer. 2014;120(13):2025–31. doi:10.1002/cncr.28682.PubMedCrossRef Percac-Lima S, Lopez L, Ashburner JM, Green AR, Atlas SJ. The longitudinal impact of patient navigation on equity in colorectal cancer screening in a large primary care network. Cancer. 2014;120(13):2025–31. doi:10.​1002/​cncr.​28682.PubMedCrossRef
19.
go back to reference Gupta S, Sussman DA, Doubeni CA, Anderson DS, Day L, Deshpande AR, et al. Challenges and possible solutions to colorectal cancer screening for the underserved. J Natl Cancer Inst. 2014;106(4):dju032. doi:10.1093/jnci/dju032 Gupta S, Sussman DA, Doubeni CA, Anderson DS, Day L, Deshpande AR, et al. Challenges and possible solutions to colorectal cancer screening for the underserved. J Natl Cancer Inst. 2014;106(4):dju032. doi:10.​1093/​jnci/​dju032
20.
21.
go back to reference Sarfaty M, Doroshenk M, Hotz J, Brooks D, Hayashi S, Davis TC, et al. Strategies for expanding colorectal cancer screening at community health centers. CA Cancer J Clin. 2013. doi:10.1002/caac.21191. Sarfaty M, Doroshenk M, Hotz J, Brooks D, Hayashi S, Davis TC, et al. Strategies for expanding colorectal cancer screening at community health centers. CA Cancer J Clin. 2013. doi:10.​1002/​caac.​21191.
22.
go back to reference Friedman LC, Everett TE, Peterson L, Ogbonnaya KI, Mendizabal V. Compliance with fecal occult blood test screening among low-income medical outpatients: a randomized controlled trial using a videotaped intervention. J Cancer Educ. 2001;16(2):85–8. doi:10.1080/08858190109528738.PubMed Friedman LC, Everett TE, Peterson L, Ogbonnaya KI, Mendizabal V. Compliance with fecal occult blood test screening among low-income medical outpatients: a randomized controlled trial using a videotaped intervention. J Cancer Educ. 2001;16(2):85–8. doi:10.​1080/​0885819010952873​8.PubMed
24.
go back to reference Matowe LK, Leister CA, Crivera C, Korth-Bradley JM. Interrupted time series analysis in clinical research. Ann Pharmacother. 2003;37(7–8):1110–6.PubMedCrossRef Matowe LK, Leister CA, Crivera C, Korth-Bradley JM. Interrupted time series analysis in clinical research. Ann Pharmacother. 2003;37(7–8):1110–6.PubMedCrossRef
25.
go back to reference Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002;27(4):299–309.PubMedCrossRef Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002;27(4):299–309.PubMedCrossRef
27.
29.
go back to reference Murphy SN, Chueh HC. A security architecture for query tools used to access large biomedical databases. Proc AMIA Symp. 2002:552–6. Murphy SN, Chueh HC. A security architecture for query tools used to access large biomedical databases. Proc AMIA Symp. 2002:552–6.
30.
go back to reference Agency for Healthcare Research and Quality. 2012 National Healthcare Disparities Report. In: U. S. Department of Health and Human Services, editor. Rockville, MD2013. Agency for Healthcare Research and Quality. 2012 National Healthcare Disparities Report. In: U. S. Department of Health and Human Services, editor. Rockville, MD2013.
31.
go back to reference Myers RE, Sifri R, Hyslop T, Rosenthal M, Vernon SW, Cocroft J, et al. A randomized controlled trial of the impact of targeted and tailored interventions on colorectal cancer screening. Cancer. 2007;110(9):2083–91. doi:10.1002/cncr.23022.PubMedCrossRef Myers RE, Sifri R, Hyslop T, Rosenthal M, Vernon SW, Cocroft J, et al. A randomized controlled trial of the impact of targeted and tailored interventions on colorectal cancer screening. Cancer. 2007;110(9):2083–91. doi:10.​1002/​cncr.​23022.PubMedCrossRef
35.
go back to reference Coughlin SS, Thompson T. Physician recommendation for colorectal cancer screening by race, ethnicity, and health insurance status among men and women in the United States, 2000. Health Promot Pract. 2005;6(4):369–78. doi:10.1177/1524839905278742.PubMedCrossRef Coughlin SS, Thompson T. Physician recommendation for colorectal cancer screening by race, ethnicity, and health insurance status among men and women in the United States, 2000. Health Promot Pract. 2005;6(4):369–78. doi:10.​1177/​1524839905278742​.PubMedCrossRef
37.
go back to reference Denberg TD, Coombes JM, Byers TE, Marcus AC, Feinberg LE, Steiner JF, et al. Effect of a mailed brochure on appointment-keeping for screening colonoscopy: a randomized trial. Ann Intern Med. 2006;145(12):895–900.PubMedCrossRef Denberg TD, Coombes JM, Byers TE, Marcus AC, Feinberg LE, Steiner JF, et al. Effect of a mailed brochure on appointment-keeping for screening colonoscopy: a randomized trial. Ann Intern Med. 2006;145(12):895–900.PubMedCrossRef
39.
go back to reference Whitaker KL, Good A, Miles A, Robb K, Wardle J, von Wagner C. Socioeconomic inequalities in colorectal cancer screening uptake: does time perspective play a role? Health Psychol. 2011;30(6):702–9. doi:10.1037/a0023941.PubMedCrossRef Whitaker KL, Good A, Miles A, Robb K, Wardle J, von Wagner C. Socioeconomic inequalities in colorectal cancer screening uptake: does time perspective play a role? Health Psychol. 2011;30(6):702–9. doi:10.​1037/​a0023941.PubMedCrossRef
Metadata
Title
Building Equity Improvement into Quality Improvement: Reducing Socioeconomic Disparities in Colorectal Cancer Screening as Part of Population Health Management
Authors
Seth A. Berkowitz, MD MPH
Sanja Percac-Lima, MD PhD
Jeffrey M. Ashburner, , MPH
Yuchiao Chang, PhD
Adrian H. Zai, MD PhD MPH
Wei He, MS
Richard W. Grant, MD MPH
Steven J. Atlas, MD MPH
Publication date
01-07-2015
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 7/2015
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-015-3227-4

Other articles of this Issue 7/2015

Journal of General Internal Medicine 7/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine